New York Life Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Buy |
315,242
+4,450
| +1% | +$206K | 0.14% | 139 |
|
|
2025
Q1 | $19M | Sell |
310,792
-4,731
| -1% | -$289K | 0.19% | 109 |
|
|
2024
Q4 | $17.8M | Buy |
315,523
+4,219
| +1% | +$239K | 0.17% | 110 |
|
|
2024
Q3 | $16.1M | Sell |
311,304
-9,881
| -3% | -$511K | 0.16% | 134 |
|
|
2024
Q2 | $13.3M | Buy |
321,185
+3,261
| +1% | +$135K | 0.13% | 154 |
|
|
2024
Q1 | $17.2M | Sell |
317,924
-11,350
| -3% | -$616K | 0.17% | 113 |
|
|
2023
Q4 | $16.9M | Sell |
329,274
-5,546
| -2% | -$285K | 0.17% | 113 |
|
|
2023
Q3 | $19.4M | Sell |
334,820
-4,346
| -1% | -$252K | 0.21% | 88 |
|
|
2023
Q2 | $21.7M | Sell |
339,166
-2,358
| -0.7% | -$151K | 0.23% | 81 |
|
|
2023
Q1 | $23.7M | Buy |
341,524
+766
| +0.2% | +$53.1K | 0.26% | 76 |
|
|
2022
Q4 | $24.5M | Sell |
340,758
-92
| -0% | -$6.62K | 0.28% | 71 |
|
|
2022
Q3 | $24.2M | Buy |
340,850
+431
| +0.1% | +$30.6K | 0.29% | 65 |
|
|
2022
Q2 | $26.2M | Buy |
+340,419
| New | +$26.2M | 0.3% | 65 |
|